People v. Lopez
REITERATIONFacts
The Antecedents: Peter Lopez y Canlas was charged with illegal sale and use of dangerous drugs under Sections 5 and 15, respectively, of Republic Act No. 9165. The charges stemmed from an alleged buy-bust operation on March 30, 2014, where Lopez was accused of selling a sachet of methamphetamine hydrochloride (shabu) and subsequently testing positive for its use. The prosecution presented evidence from the buy-bust operation, including the seized sachet and the marked money, and a chemistry report indicating Lopez's positive drug test. Procedural History: The Regional Trial Court (RTC), Fifth Judicial Region, Branch 34 of Iriga City, found Lopez guilty beyond reasonable doubt for both violations in a judgment dated July 27, 2017. Lopez appealed this decision to the Court of Appeals (CA). The CA, in its Decision dated March 29, 2019, affirmed the RTC's judgment, upholding Lopez's conviction for both offenses. Lopez subsequently filed a notice of appeal to the Supreme Court. The Petition: Lopez filed an appeal with the Supreme Court, raising the issue of whether the CA erred in affirming the RTC's judgment finding him guilty beyond reasonable doubt for violations of Sections 5 and 15, Article II of R.A. No. 9165. The Supreme Court reviewed the case and partly granted the appeal. While affirming the conviction for illegal sale of dangerous drugs (Section 5), the Court acquitted Lopez of the charge for illegal use of dangerous drugs (Section 15) due to the prosecution's failure to prove the conduct of a confirmatory drug test subsequent to the initial screening test, as required by law.
Issue(s)
Whether the Court of Appeals erred in affirming the Regional Trial Court's judgment finding the accused-appellant guilty beyond reasonable doubt for violations of Sections 5 and 15, Article II of R.A. No. 9165. Whether the prosecution sufficiently proved the elements of illegal sale of dangerous drugs under Section 5, Article II of R.A. No. 9165. Whether the prosecution sufficiently proved the elements of illegal use of dangerous drugs under Section 15, Article II of R.A. No. 9165, particularly the requirement of a confirmatory test.
Ruling
The Supreme Court partly granted the appeal. It affirmed the conviction for illegal sale of dangerous drugs (Criminal Case No. IR-10559) but acquitted the accused-appellant for illegal use of dangerous drugs (Criminal Case No. IR-10614).
Ratio Decidendi
On the charge of illegal sale of dangerous drugs (Criminal Case No. IR-10559): The Court found no compelling reason to deviate from the lower courts' findings that Lopez's guilt was proven beyond reasonable doubt. The elements of illegal sale were adequately established: the identity of the buyer, seller, object, and consideration, as well as the delivery of the drug and receipt of the marked money. PO1 Buenaflor positively identified Lopez as the seller, and the transaction was corroborated by documentary evidence. The Court rejected Lopez's defense that no prior surveillance was conducted, citing jurisprudence that the absence of prior surveillance does not affect the validity of a buy-bust operation, especially when the informant accompanies the operatives. The Court also found that the chain of custody of the seized drug was unbroken, with proper inventory, marking, photographing, and submission to the crime laboratory, despite a minor inconsistency in the described size of the sachet ('small' versus 'medium'). The integrity and identity of the corpus delicti were preserved. On the charge of illegal sale of dangerous drugs (Criminal Case No. IR-10559): The Court found no compelling reason to deviate from the lower courts' findings that Lopez's guilt was proven beyond reasonable doubt. The elements of illegal sale were adequately established: the identity of the buyer, seller, object, and consideration, as well as the delivery of the drug and receipt of the marked money. PO1 Buenaflor positively identified Lopez as the seller, and the transaction was corroborated by documentary evidence. The Court rejected Lopez's defense that no prior surveillance was conducted, citing jurisprudence that the absence of prior surveillance does not affect the validity of a buy-bust operation, especially when the informant accompanies the operatives. The Court also found that the chain of custody of the seized drug was unbroken, with proper inventory, marking, photographing, and submission to the crime laboratory, despite a minor inconsistency in the described size of the sachet ('small' versus 'medium'). The integrity and identity of the corpus delicti were preserved. On the charge of illegal use of dangerous drugs (Criminal Case No. IR-10614): The Court found that the prosecution failed to prove the conduct of a confirmatory test subsequent to the screening test, as required by law. While the forensic chemist, PSI Malong, mentioned conducting both a screening and confirmatory test, his testimony and the Chemistry Report No. DTC-081-2014 indicated that only a Thin Layer Chromatography (TLC) was performed, which is a screening test. Section 38 of R.A. No. 9165 mandates that a positive screening test must be confirmed for it to be valid in a court of law. Without the requisite confirmatory test report, Lopez could not be held criminally liable for illegal use of dangerous drugs under Section 15 of R.A. No. 9165. Consequently, an acquittal for this charge was necessary.
Main Doctrine
The prosecution must prove the elements of illegal sale of dangerous drugs beyond reasonable doubt, including the identity and integrity of the corpus delicti through an unbroken chain of custody. For illegal use of dangerous drugs, a confirmatory test subsequent to a screening test is mandatory for conviction.